RT Journal Article
SR Electronic
T1 Effects of short-term restriction of animal products on blood biomarkers and cardiovascular disease risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.17.23290094
DO 10.1101/2023.05.17.23290094
A1 Loizidou, Eleni M.
A1 Simistiras, Alexandros
A1 Barmpounakis, Petros
A1 Glentis, Stavros
A1 Dimopoulos, Alexandros
A1 Anezaki, Maria
A1 Kontoyiannis, Ioannis
A1 Demiris, Nikolaos
A1 Rouskas, Pavlos
A1 Scarmeas, Nikolaos
A1 Yannakoulia, Mary
A1 Rouskas, Konstantinos
A1 Dimas, Antigone S.
YR 2024
UL http://medrxiv.org/content/early/2024/04/16/2023.05.17.23290094.abstract
AB Dietary interventions constitute a means of untapped potential for the prevention and management of diseases including cardiovascular disease (CVD) and inflammatory disorders. The extent to which dietary modification can contribute to disease prevention and treatment however remains unclear. Here, we addressed the effects of a dietary pattern, involving periodic animal product restriction (APR), on markers of human health. We compared blood biomarkers, complete blood counts, anthropometric traits and blood pressure between two dietary states for a unique group of 200 individuals from Greece, who alternate between omnivory and APR, for religious reasons. We used linear mixed effects models to report changes in measured traits between dietary states. Short-term APR was linked to a reduction in levels of total and LDL cholesterol [both β=-0.3, p<0.0001], to a 72% decrease in CRP concentration [β=-1.3, p=0.001], to reduced platelet counts [β=-9.8, p<0.0001] and to a concurrent reduction in CVD risk (5.3% to 4.9%, p=0.02), shifting APR-practicing individuals from a high to a low-to-moderate risk group. Beneficial changes were recorded for markers of renal and liver function, with the exception of ALP [β=2.5, p<0.0001]. These changes were not detected in a control group of 211 continuously omnivorous individuals. Overall, short-term APR was linked to a biomarker profile associated with positive effects on health, suggesting that even modest dietary modifications can be harnessed towards disease prevention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe FastBio study was supported through a European Research Council Grant to Antigone Dimas (FastBio 716998)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The FastBio study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the BSRC Alexander Fleming Bioethics Committee (17-02-2017).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesPRPeriodically restrictedNRNon-restrictedT1Timepoint 1T2Timepoint 2BMIBody Mass IndexSBPSystolic Blood PressureDBPDiastolic Blood PressureLDLLow-Density LipoproteinHDLHigh-Density LipoproteinHba1cHemoglobin A1cASTAspartate AminotransferaseALTAlanine Aminotransferaseγ-GTGlutamyltransferaseALPAlkaline PhosphataseTSHThyroid-Stimulating HormoneCRPC-Reactive ProteinHOMAHomeostasis Model AssessmentHOMA-BHOMA-Beta-Cell FunctionHOMA-IRHOMA-Insulin ResistanceWBCWhite Blood CellsRBCRed Blood CellsMCHMean Corpuscular HemoglobinMCHCMean Corpuscular Hemoglobin ConcentrationRDW CVRed Cell Distribution Width Coefficient of VariationRDWSD Red Cell Distribution Width Standard DeviationPDWPlatelet Distribution WidthMPVMean Platelet VolumeP-LCRPlatelet-Large Cell RatioMAFMinor Allele FrequencyHWEHardy-Weinberg EquilibriumCVDCardiovascular disease